Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
6.62
0.29 (4.58%)
At close: Sep 24, 2025, 3:59 PM
6.50
-1.81%
After-hours: Sep 24, 2025, 07:58 PM EDT
Monte Rosa Therapeutics Revenue
Monte Rosa Therapeutics reported an annual revenue of $75.62M, reflecting a 0% growth. For the quarter ending June 30, 2025, Monte Rosa Therapeutics generated $23.19M in revenue.
Revenue (ttm)
75.62M
Revenue Growth
n/a
Price / Sales Ratio
6.78
Revenue / Employee
532.55K
Employees
142
Market Cap
408.85M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 75.62M | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |